GlassScriptPhysician profile
Richard J Simmons
NPI 1912131525
$4,394.16
in general payments reported to CMS, 2019-2025
33 companies · $1,113 in 2025
The $1,113 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $535 · 2021: $308 · 2022: $580 · 2023: $463 · 2024: $1,012 · 2025: $1,113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,507 · Education: $81.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,506.90 |
| Education | $81.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $723.22 | 2019-2025 | Briviact, Nayzilam |
| Supernus Pharmaceuticals, INC. | $670.90 | 2019-2025 | Qelbree, Qelbree |
| Abbvie INC. | $476.12 | 2022-2025 | Botox |
| Neurelis, INC. | $360.10 | 2020-2025 | Valtoco |
| Corium, LLC | $273.92 | 2022-2024 | Azstarys, Azstarys |
| Jazz Pharmaceuticals INC. | $269.05 | 2024-2025 | |
| Livanova USA, INC. | $254.50 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Biohaven Pharmaceuticals, INC. | $148.40 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $127.49 | 2022 | |
| Ironshore Pharmaceuticals INC. | $115.45 | 2021-2024 | Jornay Pm |
| Collegium Pharmaceutical, INC. | $93.60 | 2025 | Jornay Pm |
| Greenwich Biosciences, INC. | $93.36 | 2019-2020 | |
| Biocodex, INC. | $90.72 | 2023-2024 | Diacomit |
| Sk Life Science, INC. | $89.61 | 2022-2025 | |
| Upsher-Smith Laboratories LLC | $87.23 | 2020-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $71.72 | 2019-2021 | |
| Genzyme Corporation | $69.47 | 2024-2025 | |
| Catalyst Pharmaceuticals, INC. | $62.50 | 2023-2024 | Fycompa |
| Teva Pharmaceuticals USA, INC. | $34.74 | 2020-2025 | Ajovy |
| Soleno Therapeutics, INC. | $33.53 | 2025 | Vykat Xr |
| Alexion Pharmaceuticals, INC. | $29.76 | 2025 | Koselugo |
| Ipsen Biopharmaceuticals, INC | $26.55 | 2024 | Dysport |
| Astrazeneca Pharmaceuticals LP | $23.48 | 2020 | |
| Pfizer INC. | $21.20 | 2023 | |
| Eisai INC. | $20.48 | 2022 | |
| Zogenix INC. | $19.18 | 2020 | |
| Kaleo, INC. | $18.15 | 2020 | |
| Dermira, INC. | $17.75 | 2019 | |
| Biomarin Pharmaceutical INC. | $17.23 | 2022 | |
| Sunovion Pharmaceuticals INC. | $17.10 | 2019 | |
| Currax Pharmaceuticals LLC | $13.48 | 2020 | |
| Tris Pharma INC | $12.72 | 2020 | |
| Amneal Pharmaceuticals LLC | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.